Opposition · USPTO

Opposition 91301938

OtherUSPTO

Opposition 91301938 at USPTO between Palantir Technologies Inc. and EnChannel Medical Guangzhou Inc., over the mark PALANTIR, filed Sep 24, 2025. Status in the office record: other.

View PALANTIRGet this data via the API
Status
Other
Result
Other
Filed
Sep 24, 2025
Marks involved
8
Parties

Who is involved

The parties as named in the office record.

Opponent

Palantir Technologies Inc.

Company trademarks
Respondent

EnChannel Medical Guangzhou Inc.

Timeline

How the case has moved

Dates from the USPTO record and the PALANTIR filing.

  1. PALANTIR filed

    Application 98813204 filed at the USPTO.

  2. Opposition filed

    Palantir Technologies Inc. started opposition 91301938 at USPTO against PALANTIR.
Marks

Marks involved

1 contested mark, 7 marks the challenger relies on.

MarkRoleApplicationOffice
PALANTIRContested98813204USPTO
PALANTIRRelied on77111698USPTO
PALANTIRRelied on77398599USPTO
PALANTIR FOUNDRYRelied on87837494USPTO
PALANTIR FOUNDRYRelied on87837507USPTO
PALANTIRRelied on97442809USPTO
PALANTIR EDGE AIRelied on97475338USPTO
PALANTIRRelied on97975524USPTO
API

Get this data via the API

Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.

  • GET/v1/proceedings/{id}

    Parties, dates, outcome and every mark in the case

  • GET/v1/proceedings?trademark_id={trademark_id}

    Every proceeding on a mark

Get API keyView docs
GET /v1/proceedings/{id}
ID=prc_64b541ff-8716-4012-a660-d3c6d221f5a9
curl https://api.signa.so/v1/proceedings/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "prc_64b541ff-8716-4012-a660-d3c6d221f5a9",
  "object": "proceeding",
  "proceeding_type": "opposition",
  "proceeding_number": "91301938",
  "status": "other",
  "office_code": "US",
  "filed_date": "2025-09-24",
  "parties": [
    {
      "name": "Palantir Technologies Inc.",
      "role": "opponent"
    },
    {
      "name": "EnChannel Medical Guangzhou Inc.",
      "role": "respondent"
    }
  ]
}